C3.ai gets downgrade, as analyst cites concerns about subscription revenue growth

C3.ai Inc. was downgraded to underweight by KeyBanc Capital Markets Thursday, with the analyst firm citing concerns about the enterprise software company’s subscription revenue growth.

Source: MarketWatch

Earnings

Jim Cramer warns against novice day trading, calls zero-day options 'pure greed'

21. December 2024

Earnings

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

20. December 2024

Earnings

The Mega Millions jackpot is nearing $1 billion — but that’s not the only reason lottery sales could see a holiday spike

20. December 2024

Earnings

Winnebago posts its first adjusted loss in years, as consumers want cheaper RVs

20. December 2024

C3.ai gets downgrade, as analyst cites concerns about subscription revenue growth

Related Articles

Jim Cramer warns against novice day trading, calls zero-day options 'pure greed'

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The Mega Millions jackpot is nearing $1 billion — but that’s not the only reason lottery sales could see a holiday spike

Winnebago posts its first adjusted loss in years, as consumers want cheaper RVs